Expert Insight AI Drug Development: AI Agents Could Cut Clinical Trial Timelines 50%, McKinsey Reports 24 September 2025
Expert Insight Double Blow to UK Pharma: Merck and AstraZeneca Abandon £1.65bn in Investments, Branding Britain “Uncompetitive” 13 September 2025
Expert Insight From GLP-1 Black Market to Biosimilar Battle: Chinese API Suppliers Pivot to Generics After FDA Crackdown 3 September 2025
Expert Insight RFK Jr. Cancels $500M in mRNA Vaccine Development: US Government Abandons Pandemic Platform 6 August 2025
Expert Insight 7 Common Cell and Gene Therapy Manufacturing Challenges (and How To Solve Them) 17 July 2025